Live Chat

Berdagang AstraZeneca AZN

Jual
 Beli

AstraZeneca carta live

5m 15m 30m 1h 4h 1d 1w

Asas Instrumen

Weekly Search
Weekly
Daily
Tarikh Tutup Perubahan Perubahan (%): Buka Tinggi Rendah

Berita Terkini

Frances Wang 2024 Dec 17, 16:00

Nikkei 225 performance today: Beginner’s guide to Japan’s stock market

Indices Stocks
Frances Wang 2024 Dec 16, 16:00

MicroStrategy Stock Price: MSTR stock saw an increase of 0.15% today

Stocks
Frances Wang 2024 Dec 16, 16:00

Gold price today: gold holds two-day decline ahead of Fed rate cut

Commodities Gold
Frances Wang 2024 Dec 16, 16:00

Latest cryptocurrency news: What is bitcoin, Ethereum explained

Cryptocurrencies
Frances Wang 2024 Dec 15, 16:00

Broadcom stock price soars 23% as AI revenues spike 220%

Stocks
Dyogenes Diniz 2024 Dec 15, 16:00

Morning Note: Tesla Hits Record High Amid US PMI Focus and Bitcoin's Next Move

Cryptocurrencies US500 EUR USD
US interest rate and Europe inflation to guide market direction
Dyogenes Diniz 2024 Dec 13, 22:00

Week ahead: US Interest rate and Inflation in Europe to determine Markets Direction - Crucial Week

Forex Indices
Frances Wang 2024 Dec 12, 16:00

Elon Musk Net Worth Over $400 Billion as Tesla Stock Hits New Highs

TSLA

Maklumat

Sebaran nilai

66.67

Spread (%)

0.6403 %

Leveraj

1:5

Faedah semalaman (Beli)

-0.0590 %

Faedah semalaman (Jual)

-0.0299 %

Mata wang

PNC

Waktu perdagangan

Pasaran dibuka

Rabu

08:01 - 11:59

Isnin

08:01-11:59

Isnin

12:03-16:29

Selasa

08:01-11:59

Selasa

12:03-16:29

Khamis

08:01-11:59

Khamis

12:03-16:29

Jumaat

08:01-11:59

Jumaat

12:03-16:29

Analisis dan statistik

Buka

---

Tutup Terdahulu

---

Tinggi/Rendah 52 Minggu

--- – ---

Modal pasaran

164714283008

Saham Tertunggak

1550320000

Tarikh Pendapatan (Seterusnya)

0000-00-00

Hasil Div

Tarikh Selepas Dividen

2024-08-08

Kadar dividen tahunan depan

2.34

Hasil dividen tahunan depan

0.0223

EPS

3.28

Ketahui lebih lanjut mengenai instrumen ini

AstraZeneca AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Instrumen Berkaitan

Aset
Jual
Beli
Perubahan (%):

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang
Instrumen Berkaitan
Trustpilot
Live Chat